Shiny K. Kajal/LinkedIn
Mar 24, 2026, 02:55
Shiny K Kajal: FFP as a Targeted Coagulation Therapy
Shiny K. Kajal, Senior Resident at Adesh University, shared a post on LinkedIn:
”Post 27- FFP is not just ‘something to hang.’
It’s not a fluid.
It’s not a reflex.
It’s not routine.
It is targeted coagulation therapy.
If there’s no active bleeding or significant coagulopathy,
ask yourself – what exactly are you treating?
Because every unit carries risk:
TRALI. TACO. Allergic reactions. Infection.
More plasma ≠ better outcomes.
Correction ≠ clinical benefit.
Transfuse with purpose.
Dose appropriately.
Treat the patient – not the comfort of doing something.”
Shiny K. Kajal/LinkedIn
Stay updated with Hemostasis Today.
-
Apr 20, 2026, 12:14Yanki Yarman: Linking Genetic Variants to Clinical Outcomes in Thrombosis
-
Apr 20, 2026, 12:09Syed Sibtain Raza: White Blood Cells – Understanding Morphology for Better Diagnosis
-
Apr 20, 2026, 11:23Bastu Odoka: Jehovah’s Witness News on Transfusion… and a Question Worth Asking
-
Apr 20, 2026, 11:15William Aird: A Physiological Approach to Anemia
-
Apr 20, 2026, 10:59Eric Topol: Is the Interferon Pathway a Key Driver of Inflammaging and Aging
-
Apr 20, 2026, 10:47Emmanuel J Favaloro: Emerging Perspectives on Extracellular Vesicles in Hemophilia
-
Apr 20, 2026, 10:21Pierpaolo Di Micco: Honored to Join the ESVM Congress in Lausanne
-
Apr 20, 2026, 08:17Heghine Khachatryan: Key Takeaways from Day 1 – WFH 2026 World Congress
-
Apr 20, 2026, 08:10Justin Nelson-Deering։ Celebrating World Hemophilia Day in Pediatric Care